Abstract:
Background
Sphingomyelin phosphodiesterase acid-like 3B (SMPDL3B) is emerging as a potential biomarker and therapeutic target in myalgic encephalomyelitis (ME), a complex multisystem disorder characterized by immune dysfunction, metabolic disturbances, and persistent fatigue. This...
Abstract:
Background. Long COVID involves persistent symptoms after COVID-19 recovery, affecting multiple organ systems for months or years. Risk factors include female sex, prior chronic conditions, severe SARS-CoV-2 infection, reinfections, and lack of vaccination. As a major public health...
A novel estrogen receptor 1: sphingomyelin phosphodiesterase acid-like 3B pathway mediates rituximab response in myositis patients
Parkes, Joanna E; Boehler, Jessica F; Li, Ning; Kendra, Ryan M; O’Hanlon, Terrance P; Hoffman, Eric P; Peterson, Jennifer M; Miller, Frederick W; Rider, Lisa G...
YouTube: IIMEC15 07 Professor Alain Moreau 15th Invest in ME Research International ME Conference 2023
Discussion of potential biomarkers in ME/LC subgroups. References upcoming, unpublished work. Highlighted time-stamps —
9:07 MicroRNAs
18:18 SMPDL3B
27:03 FGF-21
SMPDL3B is Sphingomyelin...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.